These previous experiments were conducted in vitro, and whether differences in systemic FA availability among adults with obesity may contribute to modifications in CD36 recruitment of Fyn to IRβ and modify IRβ phosphorylation and downstream insulin action in human skeletal muscle is not known. The gene discussed is FYN; the disease is obesity disorder.